Arix leads Iterum's $65M series B

On May 19, anti-infective company Iterum Therapeutics Ltd. (Dublin, Ireland) raised $65 million in an oversubscribed series B round led by new investor Arix Bioscience plc (LSE:ARIX). New investors Pi...